Anixa Biosciences
ANIX
ANIX
58 hedge funds and large institutions have $16.5M invested in Anixa Biosciences in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.22% more ownership
Funds ownership: 14.35% → 16.56% (+2.2%)
5% less capital invested
Capital invested by funds: $17.3M → $16.5M (-$807K)
Holders
58
Holding in Top 10
–
Calls
$228K
Puts
$76K
Top Buyers
| 1 | +$835K | |
| 2 | +$734K | |
| 3 | +$312K | |
| 4 |
Jane Street
New York
|
+$245K |
| 5 |
Renaissance Technologies
New York
|
+$215K |
Top Sellers
| 1 | -$138K | |
| 2 | -$118K | |
| 3 | -$112K | |
| 4 |
CAM
Concorde Asset Management
Ann Arbor,
Michigan
|
-$60K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$55.8K |